Intrinsiqq
MeVis Medical Solutions AG logo

MeVis Medical Solutions AG Financials

M3V.XETR

⊜ Compare

All currency values in € millions unless otherwise noted

Scroll

Income Statement
SEP 2025
SEP 2024
SEP 2023
SEP 2022
SEP 2021
Revenues
Revenue€16€17€17€19€16
Cost of Revenue€0€0€0€1€0
Gross Profit€16€16€17€18€16
Total Operating Expenses€13€12€12€12€11
Operating Income€2€4€5€6€5
Non-Operating
Net Interest Expense-€0-€0-€0-€0-€0
Income Tax Expense€0€0€0€0€0
Net Income
Net Income€3€5€5€8€5
Per Share Data
Revenue Per Share€8.82€9.33€9.53€10.31€8.91
EPS (Basic)€1.74€2.51€0.00€4.28€2.50
EPS (Diluted)€1.74€2.51€0.00€4.28€2.50
Shares Outstanding1.8M1.8M1.8M1.8M1.8M
Dividends Per Share€0.95€0.95€0.95€0.00€0.00

MeVis Medical Solutions (M3V.XETR) financials: revenue, profit and margins

MeVis Medical Solutions (M3V.XETR) generated about €16 million in revenue and €3 million in net income (a 19.7% net margin) over the trailing twelve months, growing at roughly -0.2% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is MeVis Medical Solutions's (M3V.XETR) revenue?+

MeVis Medical Solutions generated about €16 million in revenue over the trailing twelve months. Revenue has grown at roughly -0.2% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is MeVis Medical Solutions profitable?+

Yes, MeVis Medical Solutions reported about €3 million in net income over the trailing twelve months, a net profit margin of roughly 19.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are MeVis Medical Solutions's profit margins?+

MeVis Medical Solutions runs a gross margin of about 97.7%, an operating margin of about 14.6%, a net margin of about 19.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is MeVis Medical Solutions growing?+

MeVis Medical Solutions's revenue has compounded at roughly -0.2% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside M3V.XETR's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Peers

Health Information Services · Pick stocks to compare with M3V.XETR

CompareIntrinsic value
GME.XETRGeratherm Medical AG
€2.13+0.00%47
AAQ1.XETRaap Implantate AG
€1.47+1.38%33
HPHA.XETRHeidelberg Pharma AG
€2.01-3.37%10
BIG1.XETRBio-Gate AG
€2.38+2.59%36
NN6.XETRNanoRepro AG
€1.58+0.32%43
FYB.XETRFormycon AG
€18.68-1.68%10
LIK.XETRLimes Schlosskliniken AG
€530.00+1.92%67
7V0.XETRDarwin AG
€6.30-3.08%24

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing M3V.XETR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.